Novel monoclonal antibodies against the proximal (carboxy-terminal) portions of MUC16

Applied Immunohistochemistry and Molecular Morphology

Volumn 18, Issue 5, 2010, Pages 462-472

  Dharma Rao, Thapi ^a   Park, Kay J ^a   Smith Jones, Peter ^a   Iasonos, Alexia ^a   Linkov, Irina ^a   Soslow, Robert A ^a   Spriggs, David R ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

antibodies; CA125; immunohistochemistry; MUC16; OC125; tissue microarray

Indexed keywords

4 A 5 ANTIBODY; 4 H 11 ANTIBODY; 9 C 9 ANTIBODY; CA 125 ANTIGEN; GLYCOPROTEIN; MONOCLONAL ANTIBODY; MUCIN; OC 125 ANTIBODY; PROTEIN MUC 16; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ANTIGEN ANTIBODY COMPLEX; ARTICLE; BREAST CANCER; CARBOXY TERMINAL SEQUENCE; CELL LINE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENETIC TRANSFECTION; GLYCOSYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; OVARY CANCER; OVARY CARCINOMA; PRIORITY JOURNAL; TISSUE SPECIFICITY; WESTERN BLOTTING;

ADENOCARCINOMA; ANTIBODIES, MONOCLONAL; BREAST NEOPLASMS; CA-125 ANTIGEN; CELL LINE, TUMOR; CELL SEPARATION; FEMALE; FLOW CYTOMETRY; HUMANS; LUNG; MALE; MEMBRANE PROTEINS; OVARY; PANCREAS; PROSTATE; TRANSGENES;

EID: 77957559349     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e3181dbfcd2     Document Type: Article

References (28)

1. Bast RC J.r., Feeney M, Lazarus H., et al. Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest. 1981; 68: 1331-1337.
2. Bast RC J.r., Klug TL, St John E, et al. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med. 1983; 309: 883-887.
3. Rustin GJ, Bast RC Jr, Kelloff GJ, et al. Use of CA-125 in clinical trial evaluation of new therapeutic drugs for ovarian cancer. Clin Cancer Res. 2004; 10: 3919-3926.
4. Rosen DG, Wang L, Atkinson J.N., et al. Potential markers that complement expression of CA125 in epithelial ovarian cancer. Gynecol Oncol. 2005; 99: 267-277.
5. Bast RC J.r., Badgwell D, Lu Z., et al. New tumor markers: CA125 and beyond. Int J Gynecol Cancer. 2005; 15(SUPPL. 3): 274-281.
6. Moore RG, Maclaughlan S, Bast RC Jr. Current state of biomarker development for clinical application in epithelial ovarian cancer. Gynecol Oncol. 2010; 116: 240-245.
7. Nustad K, Lebedin Y, Lloyd K.O., et al. Epitopes on CA125 from cervical mucus and ascites fluid and characterization of six new antibodies. Third report from the ISOBM TD-1 workshop. Tumour Biol. 2002; 23: 303-314.
8. Fendrick JL, Konishi I, Geary S.M., et al. CA125 phosphorylation is associated with its secretion from the WISH human amnion cell line. Tumour Biol. 1997; 18: 278-289.
9. Fendrick JL, Staley KA, Gee M.K., et al. Characterization of CA125 synthesized by the human epithelial amnion WISH cell line. Tumour Biol. 1993; 14: 310-318.
10. O'Brien T.J., Beard JB, Underwood L.J., et al. The CA 125 gene: a newly discovered extension of the glycosylated N-terminal domain doubles the size of this extracellular superstructure. Tumour Biol. 2002; 23: 154-169.
11. Yin BW, Dnistrian A, Lloyd KO Ovarian cancer antigen CA125 is encoded by the MUC16 mucin gene. Int J Cancer. 2002; 98: 737-740.
12. Yin BW, Lloyd KO Molecular cloning of the CA125 ovarian cancer antigen: identification as a new mucin, MUC16. J Biol Chem. 2001; 276: 27371-27375.
13. Hollingsworth M, Swanson B. Mucins in cancer: protection and control of the cell surface. Nat Rev Cancer. 2004; 4: 45-60.
14. Huang L, Ren J, Chen D., et al. MUC1 cytoplasmic domain coactivates Wnt target gene transcription and confers transformation. Cancer Biol Ther. 2003; 2: 702-706.
15. Li Q, Ren J, Kufe D. Interaction of human MUC1 and beta-catenin is regulated by Lck and ZAP-70 in activated Jurkat T cells. Biochem Biophys Res Commun. 2004; 315: 471-476.
16. Ren J, Agata N, Chen D., et al. Human MUC1 carcinoma-associated protein confers resistance to genotoxic anticancer agents. Cancer Cell. 2004; 5: 163-175.
17. Ren J, Bharti A, Raina D., et al. MUC1 oncoprotein is targeted to mitochondria by heregulin-induced activation of c-Src and the molecular chaperone HSP90. Oncogene. 2006; 25: 20-31.
18. Ramsauer VP, Pino V, Farooq A., et al. Muc4-ErbB2 complex formation and signaling in polarized CACO-2 epithelial cells indicate that Muc4 acts as an unorthodox ligand for ErbB2. Mol Biol Cell. 2006; 17: 2931-2941.
19. Bafna S, Singh AP, Moniaux N, et al. MUC4, a multifunctional transmembrane glycoprotein, induces oncogenic transformation of NIH3T3 mouse fibroblast cells. Cancer Res. 2008; 68: 9231-9238.
20. Ponnusamy MP, Singh AP, Jain M, et al. MUC4 activates HER2 signaling and enhances the motility of human ovarian cancer cells. Br J Cancer. 2008; 99: 520-526.
21. Nap M, Vitali A, Nustad K., et al. Immunohistochemical characterization of 22 monoclonal antibodies against the CA125 antigen: 2nd report from the ISOBM TD-1 Workshop. Tumour Biol. 1996; 17: 325-331. (Pubitemid 26356807)
22. Markwell MA, Fox CF Surface-specific iodination of membrane proteins of viruses and eucarytic cells using 1,3,4, 6-tetrachloro-3alpha, 6alpha-diphenylglycouril. Biochemistry. 1978; 17: 4807-4817.
23. Kononen J, Bubendorf L, Kallioniemi A., et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med. 1998; 4: 844-847.
24. Hedvat CV, Hegde A, Chaganti R.S., et al. Application of tissue microarray technology to the study of non-Hodgkin's and Hodgkin's lymphoma. Hum Pathol. 2002; 33: 968-974.
25. Soslow RA. Histologic subtypes of ovarian carcinoma: an overview. Int J Gynecol Pathol. 2008; 27: 161-174.
26. O'Brien T.J., Beard JB, Underwood L.J., et al. The CA 125 gene: an extracellular superstructure dominated by repeat sequences. Tumour Biol. 2001; 22: 348-366.
27. Harris M, Howell A, Chrissohou M., et al. A comparison of the metastatic pattern of infiltrating lobular carcinoma and infiltrating duct carcinoma of the breast. Br J Cancer. 1984; 50: 23-30.
28. Kaneko O, Gong L, Zhang J., et al. A binding domain on mesothelin for CA125/MUC16. J Biol Chem. 2009; 284: 3739-3749.